EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Suicidal ideation following ketamine prescription in patients with recurrent major depressive disorder: a nation-wide cohort study

Yiheng Pan iD, Maria P Gorenflo, Pamela B Davis, David C Kaelber, Susan De Luca, Rong Xu iD

Translational Psychiatry · 09.08.2024 · 14 (1)

DOI: 10.1038/s41398-024-03033-4 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Translational Psychiatry, online erschienen am 09.08.2024. Verfasst von Yiheng Pan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Artificial Intelligence in Drug Discovery, Case Western Reserve University School of Medicine, Cleveland, OH, USA. Hauptthemen laut MEDLINE: Ketamine, Major Depressive Disorder, Suicidal Ideation, Antidepressive Agents. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCATS NIH HHS, U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging), U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism (NIAAA).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ketamine has gained attention for its effective treatment for patients with major depressive disorder (MDD) and suicidal ideation; Despite numerous studies presenting the rapid efficacy, long-term benefit in real-world populations remains poorly characterized. This is a retrospective cohort study using TriNetX US Collaborative Network, a platform aggregating electronic health records (EHRs) data from 108 million patients from 62 health care organizations in the US, and the study population includes 514,988 patients with a diagnosis of recurrent MDD who were prescribed relevant treatment in their EHRs. The prescription of ketamine was associated with significantly decreased risk of suicidal ideation compared to the prescription of other common antidepressants: HR = 0.63 (95% CI: 0.53-0.76) at 1 day - 7 days, 0.67 (95% CI: 0.59-0.77) at 1 day - 30 days, 0.69 (95% CI: 0.62-0.77) at 1 day - 90 days, 0.74 (95% CI: 0.67-0.81) at 1 day - 180 days, and 0.78 (95% CI: 0.69-0.83) at 1 day - 270 days. This trend was especially robust among adults over 24 years of age, females, males, and White patients with recurrent MDD. This study provides real-world evidence that ketamine has long-term benefits in mitigating suicidal ideation in patients with recurrent MDD. Future work should focus on optimizing dosage regimens for ketamine, understanding the mechanism, and the difference in various demographic subpopulations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KetamineMajor Depressive DisorderSuicidal IdeationAntidepressive AgentsRecurrenceHumansMaleFemaleAdultMiddle AgedRetrospective StudiesUnited StatesYoung AdultAgedAdolescent

Substanzen

KetamineAntidepressive Agents

Autor:innen und Institutionen

  • Center for Artificial Intelligence in Drug Discovery, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
  • Department of Computer and Data Science, Case Western Reserve University, Cleveland, OH, USA.
  • Center for Community Health Integration, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
  • Center for Clinical Informatics Research and Education, The MetroHealth System, Cleveland, OH, USA.
  • Population Health Research Institute, The MetroHealth System, Cleveland, OH, USA.
  • Center for Artificial Intelligence in Drug Discovery, Case Western Reserve University School of Medicine, Cleveland, OH, USA. rxx@case.edu.

ORCID-Profile: Yiheng Pan, Rong Xu

Förderung

  • NCATS NIH HHS
  • U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging)
  • U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Zitieren

APA

Pan, Y., Gorenflo, M. P., Davis, P. B., Kaelber, D. C., De Luca, S., & Xu, R. (2024). Suicidal ideation following ketamine prescription in patients with recurrent major depressive disorder: a nation-wide cohort study. Translational Psychiatry, 14(1). https://doi.org/10.1038/s41398-024-03033-4

Vancouver

Pan Y, Gorenflo MP, Davis PB, Kaelber DC, De Luca S, Xu R. Suicidal ideation following ketamine prescription in patients with recurrent major depressive disorder: a nation-wide cohort study. Translational Psychiatry. 2024;14(1). doi:10.1038/s41398-024-03033-4

BibTeX
@article{Pan2024,
  author = {Pan, Yiheng and Gorenflo, Maria P and Davis, Pamela B and Kaelber, David C and De Luca, Susan and Xu, Rong},
  title = {Suicidal ideation following ketamine prescription in patients with recurrent major depressive disorder: a nation-wide cohort study},
  journal = {Translational Psychiatry},
  year = {2024},
  volume = {14},
  number = {1},
  doi = {10.1038/s41398-024-03033-4}
}
Kostenlos starten →